Skip to contentSkip to Braille Studio

Library / Laws / 116th Congress / Senate Bills / S. 3385

S. 3385

To strengthen the use of patient-experience data within the benefit-risk framework for approval of new drugs.

Print stageDateSize⠃
Introduced in Senate2020-03-041.4K⠃⠗⠋